Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes

British Journal of Pharmacology

Volumn 128, Issue 4, 1999, Pages 881-890

  Harper, E A ^a   Shankley, N P ^a   Black, J W ^a  

^a James Black Foundation   (United Kingdom)

Author keywords

3H clobenpropit; Guinea pig cerebral cortex; H3; Histamine; Receptor

Indexed keywords

CLOBENPROPIT; GRANISETRON; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; IDAZOXAN; METYRAPONE; PENTAZOCINE; RADIOLIGAND; RILMENIDINE; SODIUM CHLORIDE; ANTIHISTAMINIC AGENT; DRUG DERIVATIVE; GR 168320; IMIDAZOLE DERIVATIVE; PIPERIDINE DERIVATIVE; THIOPERAMIDE; THIOUREA; TRITIUM;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN MEMBRANE; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; SCATCHARD PLOT; ANIMAL; BINDING COMPETITION; GUINEA PIG; IN VITRO STUDY; KINETICS; METABOLISM; RADIOASSAY;

ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; GUINEA PIGS; HISTAMINE ANTAGONISTS; IMIDAZOLES; KINETICS; METYRAPONE; PIPERIDINES; RADIOLIGAND ASSAY; RECEPTORS, HISTAMINE H3; THIOUREA; TRITIUM;

EID: 0032589690     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702860     Document Type: Article

References (55)

1. 3-receptor in rat cerebral cortex. Br. J. Pharmacol., 118, 2045-2052.
2. Bowen, W.D., Hellewell, S.B. & Mcgarry, K.A. (1989). Evidence for a multi-site model of the rat brain a receptor. Eur. J. Pharmacol., 163, 309-318.
3. Bowen, W.D., Walker, J.M., Yashar, A.G., Matsumoto R.R., Walker, F.O. & Lorden, J.F. (1988). Altered haloperidol-sensitive sigma receptors in the genetically dystonic (dt) rat. Eur. J. Pharmacol., 147, 153-154.
4. 3), which mediates the antiestrogenic and antiproliferative effects of tamoxifen. Biochem. Biophys. Res. Commun., 134, 601-608.
5. 3) distinct from the calmodulin binding site. Cancer Chemother. Pharmacol. 18, 21-23.
6. Brandes, L.J., MacDonald, L.M. & Bogdanovic, R.P. (1985). Evidence that the antiestrogen binding site is a histamine or histamine-like receptor. Biochem. Biophys. Res. Commun., 128, 905-910.
7. Brown, J.D., O'Shaughnessfy, C.T., Kilpatrick, G.J., Scopes, D.I.C., Beswick, P., Clitherow, J.W. & Barnes, J.C. (1996). Characterisation of the specific binding of the histamine H3-receptor antagonist radioligand [3H]-GR168320. Eur. J. Pharmacol., 311, 305-310.
8. Cheng, Y.C. & Prusoff, W.H. (1973). Relationship between the inhibition constant Ki and the concentration of inhibitor which causes 50% inhibition IC50 of an enzymic reaction. Biochem. Pharmacol., 22, 3099-3108.
9. Childers, S.R. & Lariviere, G. (1984). Modification of guanine nucleotide-regulatory components in brain membranes. II Relationship of guanosine 5′-triphosphate effects on opiate receptor binding and coupling of receptors with adenylate cyclase. J. Neurosci., 4, 2674-2771.
10. 3 receptor subtypes. Br. J. Pharmacol., 107, 919-923.
11. 3-receptors on AtT-20 cells. Agents Actions, 40, 129-134.
12. 3 receptors regulate ACTH release by AtT-20 cells. Eur. J. Pharmacol., 210, 31-35.
13. 3 receptor antagonists. Bioorg. Med. Chem. Lett., 6, 833-838.
14. Convents, A., Debacker, J.P., Convents, D. & Vauquelin, G. (1987). Tight agonist binding may prevent the correct interpretation of agonist competition curves for x2-adrenergie receptors. Mol. Pharmacol., 32, 65-72.
15. Dehaven-Hudkins, D.L., Eleissner, L.C. & Ford-Rice, F.Y. (1992). Characterisation of the binding of [3H](|)-pentazocine to recognition sites in guinea-pig brain, Eur. J. Pharmacol., 227, 371-378.
16. 3 receptors from porcine brain. Br. J. Pharmacol., 122, 655-662.
17. 3-receptor agonist. J. Pharmacol. Exp. Ther., 263, 304-310.
18. 1-imidazoline-binding sites in rabbit proximal tubule cells. J. Pharmacol. Cardiovascular Pharmacol., 26, S59-S62.
19. 3H]-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium. Life Sci., 30, 1587-1595.
20. 3-receptor ligands in guinea-pig cortex and ileal longitudinal muscle myenteric plexus. Br. J. Pharmacol., 122, 43IP.
21. 3H]-clobenpropit, to sites in guinea-pig cerebral cortex membranes. Br. J. Pharmacol., 122, 432P.
22. 3-receptor radioligand binding assays in guinea-pig cerebral cortex and ileal longitudinal muscle myenteric plexus. Br. J. Pharmacol., 122, 430P.
23. Harper, E.A., Shankley, N.P. & Black, J.W. (1999). Evidence that histamine homologues discriminate between H3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus. Br. J. Pharmacol., (in press).
24. 1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms. J. Pharmacol. Exp. Ther., 272, 939-944.
25. Insel, P.A., Mahan, L.C., Motulsky, H.J., Stoolman, L.M. & Koachman, A.M. (1983). Time-dependent decreases in binding affinity of agonists for β-adrenergic receptors on intact S49 lymphoma cells. A mechanism of desensitisation. J. Biol. Chem., 258, 13597-13605.
26. James Black. (1997). Foundation Patent Applied. WO97/29092.
27. 125I]-iodophenpropit; Saturable and reversible binding in rat cortex membranes. Eur. J. Pharmacol., 217, 203-205.
28. Kent, R.S., Delean, A. & Lefkowitz, R.J. (1979). A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modelling of ligand binding data. Mol. Pharmacol., 17, 14-23.
29. α-methylhistamine to homogenates of rat and guinea-pig cortex. Agents Actions, 33, 69-75.
30. Kim, M.H. & Neubig, R.R. (1985). Parallel inactivation of α2-adrenergic binding and Ni by alkaline treatment. FEBS Lett., 192, 321-325.
31. 2 -methylhistamine. Biochem. Biophys. Res. Commun., 168, 979-986.
32. 3 receptor antagonist, thioperimide, inhibits adrenal steroidogenisis and histamine binding to adrenocortical microsomes and binds to cytochrome P450. Br. J. Pharmacol., 107, 161-164.
33. Leatherbarrow, J. (1987). Enzfitter. A non-linear regression data analysis program for the IBM PC. Biosoft.
34. 3 receptor revealed. Br. J. Pharmacol., 116, 2315-2321.
35. 3 receptor heterogeneity. J. Pharmacol. Expt. Ther., 276, 1009-1015.
36. 3-receptors. J. Pharmacol. Exp. Ther., 271, 452-459.
37. 1 receptor with quinine. J. Pharmacol. Exp. Ther., 268, 959-964.
38. 1-adrenergic receptor at cold temperature does not require a G-protein. FEBS Lett., 229, 54-59.
39. 3H]-p-aminoclonidine and [3H]-idazoxan label different populations of imidazoline sites on rat kidney. Eur. J. Pharmacol., 232, 79-87.
40. Moebius, F.F., Burrows, G.G., Hanner, M., Schmid, F., Striessing, J. & Glossman, H. (1993). Identification of a 27-kDa high affinity phenylalkylamine binding polypeptide as the σ l binding site by photoaffinity labelling and ligand-directed antibodies. Mol. Pharmacol., 44, 966-971.
41. Munson, P.J. & Rodbard, D. (1980). Ligand: a versatile computerised approach for characterisation of ligand-binding systems. Anal. Biochem., 107, 220-239.
42. 2 receptors: a quantitative autoradiographical study. Mol. Neuropharmacol., 1, 179-186.
43. 3 binding sites. Eur. J. Pharmacol., 168, 355-362.
44. 3-receptors in rat brain areas. Neuruscience, 52, 169-189.
45. 1H-cimelidine binding in guinea-pig tissue. Life Sci., 27, 199-206.
46. 3 receptor heterogeneity. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 482-488.
47. 3 receptor models. Br. J. Pharmacol., 112, 1043-1048.
48. 3 receptor. J. Med. Chem., 39, 1220-1226.
49. 3 receptor. Eur. J. Med. Chem., 27, 511-517.
50. 2 receptor. Life Sci., 33, 1119-1126.
51. Weiland, G.A. & Molinoff, P.B. (1981). Quantative analysis of drug-receptor interactions. I. Determination of kinetic and equilibrium properties. Life Sci., 29, 313-330.
52. 3-receptor. J. Neurochem., 66, 1612-1616.
53. 3-histamine receptor subtypes. Mol. Pharmacol., 38, 610-613.
54. 3H]-R-α-methylhistamine binding to rat tissues. Jpn. J. Pharmacol., 65, 107-112.
55. 3H]emopamil. Eur. J. Pharmacol., 208, 119-130.